Medicare Changes This Year - What You Need to Know

What You Need to Know About Medicare Coverage and Key Changes for 2026

Medicare in 2026 brings higher Part B premiums, negotiated drug prices on ten medications, a new prescription payment plan, and upcoming GLP-1 coverage. Here is what beneficiaries should expect.

· 5 min read
Send by email
Picture of a clipboard with an outline of Medicare coverage including Parts A, B, C, D
Credit: Adobe Stock

Premiums and Deductibles Are Going Up This Year

Medicare beneficiaries will notice higher costs across the board in 2026. The standard monthly premium for Part B, which covers doctor visits, outpatient care, and medical equipment, has risen to $202.90 per month. That is an increase of $17.90 compared to 2025. The Part B annual deductible has also climbed to $283, up from $257 last year.

The increase is largely driven by projected price changes in health care services and expected increases in how often beneficiaries use those services. However, federal officials point out that the premium hike would have been about $11 more per month had the government not taken steps to rein in excessive spending on skin substitutes, a category of wound-care products that had been driving up costs.

For Part A, which covers hospital stays, most people will not pay a premium because they have enough work history. Those who do pay will see the full premium rise to $565 per month. The Part A inpatient hospital deductible now stands at $1,736 per benefit period. Coinsurance for extended hospital stays and skilled nursing facility care has also ticked upward.

Negotiated Drug Prices Bring Real Savings

One of the biggest stories in Medicare this year is the arrival of negotiated drug prices. For the first time, the federal government has used its authority under a 2022 law to negotiate lower prices on ten of the most expensive medications covered by Part D. These drugs treat conditions like diabetes, heart failure, blood clots, arthritis, and cancer.

The discounts range from roughly 38 percent to 79 percent off previous list prices. According to federal estimates, these lower prices are expected to save beneficiaries about $1.5 billion in out-of-pocket costs in 2026 alone, while saving the Medicare program approximately $6 billion per year. Research from AARP found that out-of-pocket costs for the negotiated drugs could fall by an average of more than 50 percent for enrollees in certain stand-alone Part D plans.

All Medicare Advantage plans with drug coverage and stand-alone Part D plans are required to include these drugs on their formularies at the new prices. A second round of negotiations covering 15 additional drugs is underway, with those lower prices set to take effect in 2027.

Part D Prescription Drug Coverage Continues to Improve

Beyond negotiated prices, Part D coverage has seen several meaningful upgrades that carry forward into 2026. The annual cap on out-of-pocket prescription drug spending has increased slightly, from $2,000 to $2,100. Once a beneficiary hits that limit, the Part D plan pays the full cost for covered medications for the rest of the year. The so-called donut hole, a gap in coverage that once left many people paying full price for their drugs, remains eliminated.

The maximum Part D deductible for 2026 is $615, up from $590 last year. Some plans have lower deductibles or none at all, so it pays to compare options. Insulin copays remain capped at $35 per month, and recommended adult vaccines continue to be available at no cost through Part D.

Average premiums for stand-alone Part D plans are projected to decrease slightly, to about $34.50 per month. For Medicare Advantage plans with integrated drug coverage, the average premium drops to around $11.50 per month.

The Prescription Payment Plan Gets Easier

The Medicare Prescription Payment Plan, which launched in 2025, allows beneficiaries to spread their out-of-pocket drug costs across the year in monthly installments rather than paying large sums at the pharmacy counter. This program continues in 2026 with a welcome improvement: automatic reenrollment.

Beneficiaries who participated in the payment plan in 2025 are now automatically reenrolled for 2026 unless they chose to opt out or switched to a new Part D or Medicare Advantage plan. Those who did change plans can contact their new insurer to sign up again. If someone decides the payment plan is no longer right for them, Part D plans must process their opt-out request within three days.

This change eliminates the hassle of having to sign up every year and helps ensure continuity for those who rely on spreading their costs out month to month.

GLP-1 Weight Loss Drugs Are Coming to Medicare

Perhaps the most anticipated development in 2026 is the expansion of Medicare coverage to include popular GLP-1 medications for weight loss. Drugs like Ozempic, Wegovy, Mounjaro, and Zepbound have become household names, but they carry price tags that can exceed $1,000 a month without insurance. Until now, Medicare has only covered these drugs for conditions like diabetes or heart disease, not for weight management alone.

That is changing through a new pilot program. Starting in mid-2026, eligible Medicare Part D beneficiaries will be able to access GLP-1 medications at a cost of $50 per month. The program will initially cover people who are overweight with conditions such as prediabetes or cardiovascular disease, and will later expand to include those with higher body mass indexes who have conditions like uncontrolled high blood pressure, kidney disease, or heart failure.

A longer-term model called BALANCE is expected to launch in 2027, integrating GLP-1 coverage with lifestyle support services. An oral version of Wegovy, recently approved by the FDA, may also be included in the program.

Medicare Advantage Plans See Modest Shifts

Medicare Advantage, the private plan alternative to original Medicare, remains a popular choice. There will be roughly 5,600 plans available nationwide in 2026, only slightly fewer than the year before. Two-thirds of Medicare Advantage plans with prescription drug coverage will charge no additional premium beyond the standard Part B amount.

Average monthly premiums for Medicare Advantage are actually declining, dropping to about $14.00 from $16.40 in 2025. Nearly all plans continue to offer vision, dental, and hearing benefits, though the details of those benefits, including annual dollar caps and cost-sharing amounts, can vary widely and may change from year to year.

Some insurers have exited the market or scaled back their service areas, so beneficiaries should verify that their current plan is still available and that their preferred doctors remain in-network. About one-third of Medicare Advantage plans offer a reduction in the Part B premium as a supplemental benefit, which can help offset rising costs.

A New Prior Authorization Pilot Launches in Six States

Starting in 2026, a six-year pilot program called the WISeR Model is introducing prior authorization reviews for certain services under original Medicare in six states: Arizona, New Jersey, Ohio, Oklahoma, Texas, and Washington. The program targets services that the federal government has identified as potentially wasteful or prone to fraud.

For beneficiaries in those states, this means that some Part B services and items may require advance approval before Medicare will pay. Federal officials have emphasized that while technology, including artificial intelligence, will help support the review process, all final decisions about whether a service meets coverage requirements will be made by licensed clinicians, not machines.

This pilot does not affect Medicare Advantage enrollees, who are already subject to prior authorization through their private plans. Beneficiaries in the six states should be aware of this change and talk with their health care providers about how it may affect scheduling and approvals for certain procedures.

Practical Steps to Make the Most of Your Coverage

With so many changes taking effect, it is worth spending some time reviewing your Medicare options. Start by checking whether any of the ten negotiated drugs are medications you take regularly. If so, confirm that your Part D plan lists them and compare what your out-of-pocket costs will look like under different plans.

If you are interested in GLP-1 medications for weight management, keep an eye on announcements from the Centers for Medicare and Medicaid Services in the coming months for details on eligibility and how to enroll once coverage begins in mid-2026.

Review your Medicare Advantage plan carefully to make sure your doctors are still in-network and that the supplemental benefits you count on, like dental and vision coverage, have not changed in ways that affect you. The official Medicare Plan Finder tool at Medicare.gov is a useful resource for comparing plans side by side. And if your income is limited, check whether you qualify for Extra Help, which can significantly reduce your prescription drug costs throughout the year.